FRANKLIN LAKES, N.J.,
March 8, 2018 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, announced today that it will present at
the Barclays Global Healthcare Conference on Wednesday, March 14, 2018, at 1:35 p.m. ET.
A live webcast of BD's presentations can be accessed from the BD
corporate website at www.bd.com/investors and will be available for
replay through Wednesday, March 21,
2018.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the
delivery of care. The company supports the heroes on the frontlines
of health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its 65,000
employees have a passion and commitment to help improve patient
outcomes, improve the safety and efficiency of clinicians' care
delivery process, enable laboratory scientists to better diagnose
disease and advance researchers' capabilities to develop the next
generation of diagnostics and therapeutics. BD has a presence in
virtually every country and partners with organizations around the
world to address some of the most challenging global health issues.
By working in close collaboration with customers, BD can help
enhance outcomes, lower costs, increase efficiencies, improve
safety and expand access to health care. In 2017, BD welcomed C. R.
Bard and its products into the BD family. For more information on
BD, please visit bd.com.
Contact:
Kristen Cardillo, Communications –
201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-to-present-at-the-barclays-global-healthcare-conference-300610974.html
SOURCE BD (Becton, Dickinson and Company)